Breaking News

CEO Interviews

Natural Shrimp, Inc’s (OTCQB: SHMP) CEO Bill Williams discusses their recent joint patent and position in the Aqua-tech market.

January 28, 2019 The Wall Street Analyzer Comments Off on Natural Shrimp, Inc’s (OTCQB: SHMP) CEO Bill Williams discusses their recent joint patent and position in the Aqua-tech market.

“When we talk about growing shrimp or fish using our recirculating system; the major point is that we don’t have to be next to salt water, we can be anywhere.  That changes the nature of aquaculture.  Our technology allows us to grow shrimp and any other type of fish anywhere in the world, something that has been very elusive for other companies.”
[…]

CEO Interviews

Mr. Phil Walford CEO of Marathon Gold Group (TSX: MOZ)(OTCQX: MGDPF) discusses progress on their Valentine Gold Lake deposit in Newfoundland as the company recently put out a PEA.

January 18, 2019 The Wall Street Analyzer Comments Off on Mr. Phil Walford CEO of Marathon Gold Group (TSX: MOZ)(OTCQX: MGDPF) discusses progress on their Valentine Gold Lake deposit in Newfoundland as the company recently put out a PEA.

Marathon Gold Corp (TSX: MOZ) (OTCQX: MGDPF) CEO: Phil Walford About: Marathon is a Toronto based gold exploration company rapidly advancing its 100% owned Valentine Lake Gold Camp located in Newfoundland, one of the top […]

Biotech

Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center

January 17, 2019 The Wall Street Analyzer Comments Off on Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center

Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]

CEO Interviews

Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

July 9, 2018 The Wall Street Analyzer Comments Off on Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein   INTERVIEW TRANSCRIPTS: WSA:  Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]

CEO Interviews

Generation Next Franchise Brands (OTC: VEND) Interview with Chairman Nick Yates and CEO Arthur Budman

July 5, 2018 The Wall Street Analyzer Comments Off on Generation Next Franchise Brands (OTC: VEND) Interview with Chairman Nick Yates and CEO Arthur Budman

Generation Next Franchise Brands (OTC: VEND) Chairman: Nick Yates CEO: Arthur Budman About: Generation NEXT Franchise Brands, Inc., based in San Diego, California, is a publicly traded company on the OTC Markets trading under the symbol […]

CEO Interviews

CEO Trent Mell talks about FCC’s inclusion into the TSXV top 50 and provides an update on their Iron Creek property.

May 15, 2018 The Wall Street Analyzer Comments Off on CEO Trent Mell talks about FCC’s inclusion into the TSXV top 50 and provides an update on their Iron Creek property.

US Cobalt is focused on the acquisition and development of high grade battery metal deposits in North America. The Iron Creek Cobalt Project, located in the prolific Idaho Cobalt Belt, is the focus of a 40-hole, 35,000 foot (10,700 metre) drill campaign to confirm a 1.3M ton grading 0.59% cobalt historical estimate (non-compliant with NI 43-101) and a Resource Estimate prepared in accordance with NI 43-101 is expected on the project in 2018.
[…]